IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers
Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic...
Saved in:
Published in: | The Journal of clinical investigation Vol. 128; no. 4; pp. 1300 - 1316 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Society for Clinical Investigation
02-04-2018
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic reticulum (ER) stress and engages the inositol-requiring enzyme 1α (IRE1α)/X-box binding protein 1 (XBP1) pathway through multiple molecular mechanisms in a variety of c-Myc- and N-Myc-dependent cancers. In particular, Myc-overexpressing cells require IRE1α/XBP1 signaling for sustained growth and survival in vitro and in vivo, dependent on elevated stearoyl-CoA-desaturase 1 (SCD1) activity. Pharmacological and genetic XBP1 inhibition induces Myc-dependent apoptosis, which is alleviated by exogenous unsaturated fatty acids. Of note, SCD1 inhibition phenocopies IRE1α RNase activity suppression in vivo. Furthermore, IRE1α inhibition enhances the cytotoxic effects of standard chemotherapy drugs used to treat c-Myc-overexpressing Burkitt's lymphoma, suggesting that inhibiting the IRE1α/XBP1 pathway is a useful general strategy for treatment of Myc-driven cancers. |
---|---|
AbstractList | Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic reticulum (ER) stress and engages the inositol-requiring enzyme 1a (IRE1a)/X-box binding protein 1 (XBP1) pathway through multiple molecular mechanisms in a variety of c-Myc- and N-Myc-dependent cancers. In particular, Myc-overexpressing cells require IRE1a/XBP1 signaling for sustained growth and survival in vitro and in vivo, dependent on elevated stearoyl-CoA-desaturase 1 (SCD1) activity. Pharmacological and genetic XBP1 inhibition induces Myc-dependent apoptosis, which is alleviated by exogenous unsaturated fatty acids. Of note, SCD1 inhibition phenocopies IRE1a RNase activity suppression in vivo. Furthermore, IRE1a inhibition enhances the cytotoxic effects of standard chemotherapy drugs used to treat c-Myc-overexpressing Burkitt's lymphoma, suggesting that inhibiting the IRE1a/XBP1 pathway is a useful general strategy for treatment of Myc-driven cancers. Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting that Myc-dependent downstream effectors may be more tractable therapeutic targets. Here, we show that Myc overexpression induces endoplasmic reticulum (ER) stress and engages the inositol-requiring enzyme 1α (IRE1α)/X-box binding protein 1 (XBP1) pathway through multiple molecular mechanisms in a variety of c-Myc- and N-Myc-dependent cancers. In particular, Myc-overexpressing cells require IRE1α/XBP1 signaling for sustained growth and survival in vitro and in vivo, dependent on elevated stearoyl-CoA-desaturase 1 (SCD1) activity. Pharmacological and genetic XBP1 inhibition induces Myc-dependent apoptosis, which is alleviated by exogenous unsaturated fatty acids. Of note, SCD1 inhibition phenocopies IRE1α RNase activity suppression in vivo. Furthermore, IRE1α inhibition enhances the cytotoxic effects of standard chemotherapy drugs used to treat c-Myc-overexpressing Burkitt's lymphoma, suggesting that inhibiting the IRE1α/XBP1 pathway is a useful general strategy for treatment of Myc-driven cancers. |
Author | Del Valle, Juan R Tang, Chih-Hang Anthony Xiang, Yan Hu, Chih-Chi Andrew Lan, Roy Keith, Brian Sanchez, Danielle J Dang, Chi V Song, Jun H Xie, Hong Cao, Jin Mancuso, Anthony Simon, M Celeste |
AuthorAffiliation | 3 The Wistar Institute, Philadelphia, Pennsylvania, USA 1 Abramson Family Cancer Research Institute and 4 Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA 2 Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA 8 Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA 7 Lester and Sue Smith Breast Center, and 6 Department of Molecular and Cellular Biology 5 Department of Chemistry, University of South Florida, Tampa, Florida, USA |
AuthorAffiliation_xml | – name: 4 Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA – name: 7 Lester and Sue Smith Breast Center, and – name: 1 Abramson Family Cancer Research Institute and – name: 6 Department of Molecular and Cellular Biology – name: 8 Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA – name: 3 The Wistar Institute, Philadelphia, Pennsylvania, USA – name: 2 Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA – name: 5 Department of Chemistry, University of South Florida, Tampa, Florida, USA |
Author_xml | – sequence: 1 givenname: Hong surname: Xie fullname: Xie, Hong organization: Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA – sequence: 2 givenname: Chih-Hang Anthony surname: Tang fullname: Tang, Chih-Hang Anthony organization: The Wistar Institute, Philadelphia, Pennsylvania, USA – sequence: 3 givenname: Jun H surname: Song fullname: Song, Jun H organization: Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA – sequence: 4 givenname: Anthony surname: Mancuso fullname: Mancuso, Anthony organization: Abramson Family Cancer Research Institute and – sequence: 5 givenname: Juan R surname: Del Valle fullname: Del Valle, Juan R organization: Department of Chemistry, University of South Florida, Tampa, Florida, USA – sequence: 6 givenname: Jin surname: Cao fullname: Cao, Jin organization: Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA – sequence: 7 givenname: Yan surname: Xiang fullname: Xiang, Yan organization: Abramson Family Cancer Research Institute and – sequence: 8 givenname: Chi V surname: Dang fullname: Dang, Chi V organization: Abramson Family Cancer Research Institute and – sequence: 9 givenname: Roy surname: Lan fullname: Lan, Roy organization: Abramson Family Cancer Research Institute and – sequence: 10 givenname: Danielle J surname: Sanchez fullname: Sanchez, Danielle J organization: Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA – sequence: 11 givenname: Brian surname: Keith fullname: Keith, Brian organization: Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA – sequence: 12 givenname: Chih-Chi Andrew surname: Hu fullname: Hu, Chih-Chi Andrew organization: The Wistar Institute, Philadelphia, Pennsylvania, USA – sequence: 13 givenname: M Celeste surname: Simon fullname: Simon, M Celeste organization: Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29381485$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkd1q3DAQhUVJSDbbQJ-gGHqTGzcjS7Klm0JZNsmW_MDSXAutPG4UbMmV7IU8Vl8kzxSHbn7aq7mYwzdnzjkiez54JOQTha-UVsXpj8VKCVnyD2RGhZC5LJjcIzOAguaqYvKQHKV0D0A5F_yAHBaKScqlmJHb1XpJH_9k62uTMK-xR1-jH7LW9a7O7kKHIQ0muZT1MXRhwJSlMW7d1rSZ89nVg82HaHxqQuywzqzxFmP6SPYb0yY83s05uT1b_lxc5Jc356vF98vccoAhRwaN2tAaG1srKmvJ6kKCKivYYCMtcNxwq7g0k9-qAWaFgVIoQYUqOaOCzcm3v9x-3Ezn7eQ8mlb30XUmPuhgnP53492d_hW2WsgpFakmwMkOEMPvEdOgO5cstq3xGMakqVIMoCymEOfky3_S-zBGP72nCxBlpUoJ8Aa0MaQUsXk1Q0E_d6Vfupqkn9-bfxW-lMOeABpUkVA |
CitedBy_id | crossref_primary_10_1016_j_jpedsurg_2023_02_037 crossref_primary_10_1038_s41467_021_25684_3 crossref_primary_10_1016_j_molmed_2018_05_005 crossref_primary_10_1038_s41392_021_00500_y crossref_primary_10_1111_bjh_19425 crossref_primary_10_1158_0008_5472_CAN_22_2679 crossref_primary_10_1038_s41388_021_02108_6 crossref_primary_10_1101_cshperspect_a041542 crossref_primary_10_1016_j_trecan_2022_06_006 crossref_primary_10_1126_scitranslmed_aar7535 crossref_primary_10_1016_j_chembiol_2023_08_011 crossref_primary_10_1038_s41467_022_30159_0 crossref_primary_10_4049_immunohorizons_2200064 crossref_primary_10_1038_s41568_020_00312_2 crossref_primary_10_3389_fcell_2021_683940 crossref_primary_10_1016_j_tips_2020_11_014 crossref_primary_10_3389_fonc_2020_00562 crossref_primary_10_1016_j_bbrc_2022_04_108 crossref_primary_10_3389_fgene_2022_949314 crossref_primary_10_1172_JCI151591 crossref_primary_10_15252_emmm_201911845 crossref_primary_10_3390_ijms23169113 crossref_primary_10_1016_j_pharmthera_2023_108413 crossref_primary_10_1002_1878_0261_12835 crossref_primary_10_1016_j_jep_2018_05_039 crossref_primary_10_1038_s41401_023_01225_0 crossref_primary_10_1021_acsnano_1c04068 crossref_primary_10_1038_s41388_019_0912_5 crossref_primary_10_3390_ijms24010589 crossref_primary_10_1007_s11523_022_00870_5 crossref_primary_10_1038_s41580_020_0227_y crossref_primary_10_3390_cancers14215340 crossref_primary_10_1038_s41375_024_02321_8 crossref_primary_10_1093_abbs_gmab131 crossref_primary_10_1016_j_biopha_2020_110069 crossref_primary_10_1016_j_biopha_2022_113741 crossref_primary_10_1074_jbc_RA119_008353 crossref_primary_10_1111_jcmm_16255 crossref_primary_10_1158_0008_5472_CAN_21_1545 crossref_primary_10_3389_fphar_2024_1322557 crossref_primary_10_1016_j_bbcan_2018_05_003 crossref_primary_10_15252_emmm_202114764 crossref_primary_10_1016_j_cmet_2019_07_012 crossref_primary_10_1186_s10020_024_00808_9 crossref_primary_10_1158_2767_9764_CRC_23_0030 crossref_primary_10_3390_ijms21176314 crossref_primary_10_2139_ssrn_4152835 crossref_primary_10_1172_JCI95873 crossref_primary_10_14336_AD_2022_0824 crossref_primary_10_1016_j_isci_2022_105183 crossref_primary_10_1016_j_molcel_2019_10_014 crossref_primary_10_1080_2162402X_2022_2116844 crossref_primary_10_1128_spectrum_02636_23 crossref_primary_10_15252_embr_202152509 crossref_primary_10_1016_j_molcel_2019_09_008 crossref_primary_10_1002_art_41883 crossref_primary_10_1016_j_tips_2024_04_007 crossref_primary_10_1158_2643_3230_BCD_22_0162 crossref_primary_10_1038_s41388_024_02988_4 crossref_primary_10_3390_ijms24065493 crossref_primary_10_1158_0008_5472_CAN_19_3108 crossref_primary_10_1080_14728222_2023_2293746 crossref_primary_10_1021_acs_molpharmaceut_1c00639 crossref_primary_10_1038_s41589_019_0326_2 crossref_primary_10_3390_cancers14102526 crossref_primary_10_5604_01_3001_0011_7381 crossref_primary_10_1016_j_cmet_2022_10_010 crossref_primary_10_1038_s41420_021_00696_6 crossref_primary_10_1039_C9NP00066F crossref_primary_10_1016_j_trecan_2019_12_001 crossref_primary_10_1084_jem_20201606 crossref_primary_10_1016_j_phrs_2020_105131 crossref_primary_10_3390_cells11081265 crossref_primary_10_1016_j_biopha_2022_112747 crossref_primary_10_1038_s41401_020_00505_3 crossref_primary_10_1016_j_canlet_2018_06_012 crossref_primary_10_1016_j_it_2018_12_001 crossref_primary_10_1158_1535_7163_MCT_20_0127 crossref_primary_10_1016_j_intimp_2020_106930 crossref_primary_10_1186_s13046_020_01702_y crossref_primary_10_1128_JVI_01229_20 crossref_primary_10_1021_acs_jmedchem_9b00269 crossref_primary_10_3389_fonc_2020_01100 crossref_primary_10_1038_s41589_020_00654_w crossref_primary_10_1146_annurev_pathol_061020_050135 crossref_primary_10_1038_s41416_020_01119_6 crossref_primary_10_3390_biomedicines9020156 crossref_primary_10_1016_j_csbj_2023_08_009 crossref_primary_10_1016_j_drup_2023_100963 |
Cites_doi | 10.1038/nature21064 10.1038/onc.2008.312 10.1016/j.tcb.2013.06.005 10.1101/cshperspect.a014415 10.1158/1078-0432.CCR-12-3249 10.3945/an.110.000125 10.1101/cshperspect.a014241 10.1101/cshperspect.a014282 10.1016/S0140-6736(11)61177-X 10.1126/science.287.5453.664 10.1038/ncb3266 10.1021/ac202220b 10.1186/gb-2003-4-10-r69 10.1101/cshperspect.a014266 10.1016/j.cmet.2012.09.004 10.1084/jem.192.8.1183 10.1128/MCB.23.21.7448-7459.2003 10.1126/science.1158042 10.1182/blood-2011-07-366633 10.1016/j.ccr.2014.03.015 10.1038/nature07449 10.1016/j.tem.2016.01.001 10.1172/JCI62973 10.1016/j.ccell.2014.11.024 10.1007/s10616-010-9263-3 10.1371/journal.pone.0011621 10.1016/j.cell.2012.03.003 10.1038/nature12138 10.1083/jcb.200903014 10.1038/sj.onc.1211017 10.1073/pnas.1307237110 10.1038/nrm3270 10.1073/pnas.0901230107 10.1016/j.trecan.2016.03.007 10.1172/JCI75836 10.1084/jem.20080809 10.4049/jimmunol.0900953 10.1073/pnas.1115623109 10.1139/o59-099 10.1158/2159-8290.CD-12-0418 10.1016/B978-0-12-385114-7.00004-0 10.1182/blood-2011-11-394346 10.1172/JCI73448 10.1016/j.molcel.2007.06.011 10.1101/gad.198630.112 10.1038/nature13119 10.1073/pnas.1217611110 10.1016/j.cell.2015.06.017 10.1371/journal.pgen.1003664 10.1101/gad.14.11.1390 10.1074/jbc.M112.412783 10.1002/cmdc.200600294 10.1073/pnas.1409778111 10.1016/j.cell.2011.08.017 10.1016/j.cell.2015.05.025 10.1158/2159-8290.CD-14-1507 10.1038/ng1532 10.1371/journal.pone.0033823 10.1016/j.bbrc.2015.05.061 |
ContentType | Journal Article |
Copyright | Copyright American Society for Clinical Investigation Apr 2018 Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation |
Copyright_xml | – notice: Copyright American Society for Clinical Investigation Apr 2018 – notice: Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation |
DBID | NPM AAYXX CITATION 3V. 7RV 7X7 7XB 88A 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PQEST PQQKQ PQUKI PRINS S0X 7X8 5PM |
DOI | 10.1172/JCI95864 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection eLibrary AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef ProQuest Central Student ProQuest Central Essentials SIRS Editorial elibrary ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student PubMed |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-8238 |
EndPage | 1316 |
ExternalDocumentID | 10_1172_JCI95864 29381485 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA057341 – fundername: NCI NIH HHS grantid: P01 CA104838 – fundername: NCI NIH HHS grantid: R21 CA199553 – fundername: NCI NIH HHS grantid: R01 CA163910 – fundername: NICHD NIH HHS grantid: T32 HD083185 – fundername: NCI NIH HHS grantid: P30 CA010815 – fundername: NCI NIH HHS grantid: R01 CA190860 – fundername: ; grantid: CA199553 – fundername: ; grantid: CA190860 – fundername: ; grantid: N/A – fundername: ; grantid: CA104838 – fundername: ; grantid: CA163910 |
GroupedDBID | --- -~X .55 .XZ 08G 08P 29K 354 36B 3V. 5GY 5RE 5RS 7RV 7X7 88A 88E 8AO 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAWTL ABOCM ABPMR ABUWG ACGFO ACIHN ACNCT ACPRK ADBBV AEAQA AENEX AFCHL AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS ASPBG AVWKF AZFZN BAWUL BBNVY BCU BEC BENPR BHPHI BKEYQ BLC BPHCQ BVXVI CCPQU CS3 D-I DIK DU5 E3Z EBD EBS EJD EMB EMOBN EX3 F5P FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR IHW INH INR IOF IOV IPO ISR ITC KQ8 L7B LK8 M0L M1P M5~ M7P NAPCQ NPM OBH OCB ODZKP OFXIZ OGEVE OHH OK1 OVD OVIDX P2P P6G PQQKQ PROAC PSQYO Q2X RPM S0X SJFOW SV3 TEORI TR2 TVE UKHRP VVN W2D WH7 WOQ WOW X7M XSB YFH YHG YKV YOC ZY1 ~H1 AAYXX CITATION 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c400t-e30f9b1defcd918d83d2809670bef8c04eb4c948a2937f03c5a06595159643153 |
IEDL.DBID | RPM |
ISSN | 0021-9738 |
IngestDate | Tue Sep 17 21:24:45 EDT 2024 Fri Oct 25 11:59:27 EDT 2024 Sun Nov 24 01:51:13 EST 2024 Thu Sep 26 17:13:49 EDT 2024 Wed Oct 16 00:51:36 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Oncology Cell stress Drug therapy Therapeutics Cancer |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c400t-e30f9b1defcd918d83d2809670bef8c04eb4c948a2937f03c5a06595159643153 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-9024-2932 0000-0002-5097-5709 |
OpenAccessLink | http://www.jci.org/articles/view/95864/files/pdf |
PMID | 29381485 |
PQID | 2056796800 |
PQPubID | 42166 |
PageCount | 17 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5873889 proquest_miscellaneous_1993006297 proquest_journals_2056796800 crossref_primary_10_1172_JCI95864 pubmed_primary_29381485 |
PublicationCentury | 2000 |
PublicationDate | 2018-04-02 |
PublicationDateYYYYMMDD | 2018-04-02 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Ann Arbor |
PublicationTitle | The Journal of clinical investigation |
PublicationTitleAlternate | J Clin Invest |
PublicationYear | 2018 |
Publisher | American Society for Clinical Investigation |
Publisher_xml | – name: American Society for Clinical Investigation |
References | B20 B22 B23 B25 B26 B27 B28 B29 B30 B31 B32 B33 B34 B35 B36 B37 B38 B39 B1 Huang (B43) 2013; 3 B4 B5 B6 B8 B9 Zhao (B47) Gabay (B3) 2014; 4 B40 B41 B42 B44 B45 B46 B48 B49 Schmitz (B16) 2014; 4 B50 Liu (B21) 2017; 8 B51 B52 B53 B10 B54 B11 B55 B12 B56 B13 B57 B14 B58 B15 B59 McKeown (B7) 2014; 4 B17 B18 B19 Malynn (B2) 2000; 14 B60 Oslowski (B24) 2011; 490 B61 B62 B63 |
References_xml | – ident: B55 doi: 10.1038/nature21064 – ident: B44 doi: 10.1038/onc.2008.312 – ident: B12 doi: 10.1016/j.tcb.2013.06.005 – volume: 3 issue: 10 year: 2013 ident: B43 article-title: Neuroblastoma and MYCN publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a014415 contributor: fullname: Huang – ident: B50 doi: 10.1158/1078-0432.CCR-12-3249 – ident: B51 doi: 10.3945/an.110.000125 – volume: 4 issue: 6 year: 2014 ident: B3 article-title: MYC activation is a hallmark of cancer initiation and maintenance publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a014241 contributor: fullname: Gabay – volume: 4 issue: 2 year: 2014 ident: B16 article-title: Oncogenic mechanisms in Burkitt lymphoma publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a014282 contributor: fullname: Schmitz – ident: B27 doi: 10.1016/S0140-6736(11)61177-X – ident: B28 doi: 10.1126/science.287.5453.664 – ident: B22 doi: 10.1038/ncb3266 – ident: B34 doi: 10.1021/ac202220b – ident: B38 doi: 10.1186/gb-2003-4-10-r69 – volume: 4 issue: 10 year: 2014 ident: B7 article-title: Therapeutic strategies to inhibit MYC publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a014266 contributor: fullname: McKeown – ident: B19 doi: 10.1016/j.cmet.2012.09.004 – ident: B62 doi: 10.1084/jem.192.8.1183 – ident: B13 doi: 10.1128/MCB.23.21.7448-7459.2003 – ident: B26 doi: 10.1126/science.1158042 – ident: B56 doi: 10.1182/blood-2011-07-366633 – ident: B45 doi: 10.1016/j.ccr.2014.03.015 – ident: B8 doi: 10.1038/nature07449 – ident: B31 doi: 10.1016/j.tem.2016.01.001 – ident: B10 doi: 10.1172/JCI62973 – ident: B52 doi: 10.1016/j.ccell.2014.11.024 – ident: B41 doi: 10.1007/s10616-010-9263-3 – ident: B60 doi: 10.1371/journal.pone.0011621 – ident: B1 doi: 10.1016/j.cell.2012.03.003 – ident: B39 doi: 10.1038/nature12138 – ident: B15 doi: 10.1083/jcb.200903014 – volume: 8 year: 2017 ident: B21 article-title: A critical role of DDRGK1 in endoplasmic reticulum homoeostasis via regulation of IRE1α stability publication-title: Nat Commun contributor: fullname: Liu – ident: B59 doi: 10.1038/sj.onc.1211017 – ident: B53 doi: 10.1073/pnas.1307237110 – ident: B9 doi: 10.1038/nrm3270 – ident: B20 doi: 10.1073/pnas.0901230107 – ident: B46 doi: 10.1016/j.trecan.2016.03.007 – ident: B63 doi: 10.1172/JCI75836 – ident: B18 doi: 10.1084/jem.20080809 – ident: B33 doi: 10.4049/jimmunol.0900953 – ident: B25 doi: 10.1073/pnas.1115623109 – ident: B47 article-title: Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer publication-title: J Clin Invest contributor: fullname: Zhao – ident: B61 doi: 10.1139/o59-099 – ident: B6 doi: 10.1158/2159-8290.CD-12-0418 – volume: 490 start-page: 71 year: 2011 ident: B24 article-title: Measuring ER stress and the unfolded protein response using mammalian tissue culture system publication-title: Meth Enzymol doi: 10.1016/B978-0-12-385114-7.00004-0 contributor: fullname: Oslowski – ident: B58 doi: 10.1182/blood-2011-11-394346 – ident: B23 doi: 10.1172/JCI73448 – ident: B14 doi: 10.1016/j.molcel.2007.06.011 – ident: B37 doi: 10.1101/gad.198630.112 – ident: B57 doi: 10.1038/nature13119 – ident: B49 doi: 10.1073/pnas.1217611110 – ident: B40 doi: 10.1016/j.cell.2015.06.017 – ident: B11 doi: 10.1371/journal.pgen.1003664 – volume: 14 start-page: 1390 issue: 11 year: 2000 ident: B2 article-title: N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation publication-title: Genes Dev doi: 10.1101/gad.14.11.1390 contributor: fullname: Malynn – ident: B29 doi: 10.1074/jbc.M112.412783 – ident: B4 doi: 10.1002/cmdc.200600294 – ident: B35 doi: 10.1073/pnas.1409778111 – ident: B5 doi: 10.1016/j.cell.2011.08.017 – ident: B32 doi: 10.1016/j.cell.2015.05.025 – ident: B48 doi: 10.1101/gad.198630.112 – ident: B36 doi: 10.1073/pnas.1307237110 – ident: B54 doi: 10.1158/2159-8290.CD-14-1507 – ident: B17 doi: 10.1038/ng1532 – ident: B42 doi: 10.1371/journal.pone.0033823 – ident: B30 doi: 10.1016/j.bbrc.2015.05.061 |
SSID | ssj0014454 |
Score | 2.5805836 |
Snippet | Myc activation is a primary oncogenic event in many human cancers; however, these transcription factors are difficult to inhibit pharmacologically, suggesting... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1300 |
SubjectTerms | Activating transcription factor 1 Apoptosis Biomedical research Breast cancer Burkitt's lymphoma c-Myc protein Cancer therapies Chemotherapy Cytotoxicity Desaturase Drug development Endoplasmic reticulum Enzymes Fatty acids Homeostasis Inositol Kinases Lipids Lymphoma Metabolism Molecular modelling Myc protein Neuroblastoma Physiology Proteins Ribonuclease Sensors Therapeutic applications Transcription factors Tumorigenesis |
Title | IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29381485 https://www.proquest.com/docview/2056796800 https://search.proquest.com/docview/1993006297 https://pubmed.ncbi.nlm.nih.gov/PMC5873889 |
Volume | 128 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTsMwEB1RFogN4k_5yUhsQ5sm7thLVIoKUivER7CLGtsRkdq0Iu2CHXfgJFyEQ3ASxmlcUdixtvMbjz1vMs_PAKcyjlFTouAZYUW1KQZ6shmjp9Gg8mn2NYufOZ077D2Ji7aVyeFuL0xB2ldxepYNhmdZ-lxwK8dDVXM8sdpNt8UFBkLIWgUqhA1dil6WDsKQl9LLviepX6k4S4G6dt26klw07Vk8FOUEZQJ8MRz9wZi_qZI_Ys_lOqyVoJGdz15uA5ZMtgkr3bIsvgWPV7dt__OD3fYoJn29vbuTbSdskI5TzZ5HQzMiGJinORsX_DuTs3xKqwT5GUsz1n1V3sRBWKOZsr7wkm_Dw2X7vtXxyhMTPEVzceKZoJ7I2NcmUVr6QotANwQlKViPTSJUPTRxqGQo-vT5mNQDxfu2rmoxDSETWvx2YDkbZWYPGBpf0mqAwkcTJhj0uQwoddQ8DhG5NFU4cYaLxjNhjKhIKLAROTtX4dBZNCqnRh41CHKhbBJQpVvMm8mpbaWin5nRNI8sq9Du7pRYhd3ZAMwf4kauCrgwNPMOVjB7sYX8qBDOLv1m_99XHsAqASZRMHcah7A8eZmaI6jkenpcOOE3-UniGA |
link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTuMwEB4trMRyYRd2gS4sGIlraNLEHfuIukXtQivEj9hb1NiOGommFWkP3HgHnoQX2YfgSRincbXdvXG240T-PJ5vMuPPAMcySVBToOAZYUW1yQd6spmgp9GgCsj6muXPnM419n-Ln20rk8PdWZiyaF8l2Ul-PzrJs2FZWzkZqbqrE6tf9lpcYCiErK_AR7JX33dBepU8iCJeiS8HnqSeleYsuer6r1ZXctG0t_GQnxMUC_Blh_Qfy_y3WPIv73P2-Z3f_QU2KrrJTufNm_DB5Fuw1qsS6l_hrnvVDv68sKs-ebPXp2d3J-6U3WeTTLPheGTGRCCLrGCTsnLPFKyY0f5CK5RlOes9Km_qyK_RTNlV9FB8g9uz9k2r41V3LXiKrHjqmdBPZRJokyotA6FFqBuCwhv0E5MK5UcmiZSMxICmDVM_VHxgM7KWDRGnoW1zG1bzcW52gaEJJO0jKAI0UYrhgMuQgk7NkwiRS1ODIzfh8WQuqRGXoQg2YodPDfYdEnFlVEXcILKGskmA0xCLZjIHm-MY5GY8K2Jbj2jPhUqswc4cuMVLHOI1wCVIFx2s1PZyCyFZSm5XyH1_95OH8Klz07uIL7r98z1YJ9olyvqfxj6sTh9m5gesFHp2UC7kN3mg97A |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTuNAEC2xSIgLyzBA2KaRuBrvqe4jCokIM4kQzGjmZsXdbWGJOBZODtz4B76EH-Ej-BKqHTsiww3O3V7Ur6vrlav8CuBExDEqChQszY2oNvlASzRjtBRqlC5ZX7P8mHNxg_1__LxtZHJmrb7Kon0Zp6fZ3fA0S2_L2sp8KO26Tsy-6rVCjj7nws5VYi_CMtms49WBepVACIKwEmB2LUGzK91Zctf2ZasrQt40HXnI13GKB8J5p_SBaf5fMPnOA3XWv_DuG7BW0U52Np2yCQs6-wYrvSqxvgV_u9dt9-WZXffJq70-PtW9ccfsLs1TxW5HQz0iIlmkBcvLCj5dsGJC5wztVJZmrPcgrXFNgrVi0uym--I7_Om0f7curKrngiXJmseW9p1ExK7SiVTC5Yr7yuMU5qAT64RLJ9BxIEXAB7R0mDi-DAcmM2tYEXEbOj63YSkbZXoXGGpX0HmC3EUdJOgPQuFT8KnCOEAMhW7Acb3oUT6V1ojKkAS9qMaoAQc1GlFlXEXkEWlD0SSqS7eYDZNZmFzHINOjSRGZukTzf6jABuxMwZs9pEa9ATgH62yCkdyeHyE0S-ntCr29T1_5A1auzjvRr27_5z6sEvviZRmQdwBL4_uJPoTFQk2Oyr38Bkoi-jA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IRE1%CE%B1+RNase-dependent+lipid+homeostasis+promotes+survival+in+Myc-transformed+cancers&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Xie%2C+Hong&rft.au=Tang%2C+Chih-Hang+Anthony&rft.au=Song%2C+Jun+H&rft.au=Mancuso%2C+Anthony&rft.date=2018-04-02&rft.eissn=1558-8238&rft.volume=128&rft.issue=4&rft.spage=1300&rft.epage=1316&rft_id=info:doi/10.1172%2FJCI95864&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon |